The functional significance of genetic variation within the β₁-adrenoceptorSANDILANDS, A. J; O'SHAUGHNESSY, K. M.British journal of clinical pharmacology. 2005, Vol 60, Num 3, pp 235-243, issn 0306-5251, 9 p.Article

Receptor gene polymorphisms: lessons on functional relevance from the β₁-adrenoceptorMICHEL, Martin C; INSEL, Paul A.British journal of pharmacology. 2003, Vol 138, Num 2, pp 279-282, issn 0007-1188, 4 p.Article

Role of β1-adrenoceptor in increased lipolysis in cancer cachexiaCAO, Dong-Xing; WU, Guo-Hao; XI, Qiu-Lei et al.Cancer science. 2010, Vol 101, Num 7, pp 1639-1645, issn 1347-9032, 7 p.Article

Insulin-like growth factor-I provokes functional antagonism and internalization of β₁-Adrenergic receptorsGAVI, Shai; DEZHONG YIN; SHUMAY, Elena et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 6, pp 2653-2662, issn 0013-7227, 10 p.Article

The putative β₄-adrenergic receptor is a novel state of the β₁-adrenergic receptorGRANNEMAN, James G.American journal of physiology. Endocrinology and metabolism. 2001, Vol 43, Num 2, pp E199-E202, issn 0193-1849Article

In-vivo studies do not support a major functional role for the Gly³⁸⁹Arg β₁-adrenoceptor polymorphism in humansBÜSCHER, Rainer; BELGER, Heiko; EILMES, Katrin J et al.Pharmacogenetics (London). 2001, Vol 11, Num 3, pp 199-205, issn 0960-314XArticle

Betaxolol in anxiety disordersSWARTZ, C. M.Annals of clinical psychiatry. 1998, Vol 10, Num 1, pp 9-14, issn 1040-1237Article

Autoantikörper gegen den β₁-adrenergen Rezeptor bei Myokarditis und dilatativer Kardiomyopathie : Lokalisation von zwei Epitopen = Autoantibodies against the β₁-adrenoceptors in myocarditis and dilated cardiomyopathy: localization of two epitopesWALLUKAT, G; MORWINSKI, R; MAGNUSSON, Y et al.Zeitschrift für Kardiologie. Supplementum. 1992, Vol 81, Num 4, pp 79-83, issn 0303-6308Conference Paper

EsmolodRAMSAY, J. G.Canadian journal of anaesthesia. 1991, Vol 38, Num 2, pp 155-158, issn 0832-610X, 4 p.Article

Pharmacokinetics of intravenous bisoprolol in obese and non-obes volunteersLE JEUNNE, C; POIRIER, J. M; CHEYMOL, G et al.European journal of clinical pharmacology. 1991, Vol 41, Num 2, pp 171-174, issn 0031-6970Article

Coexistence of β₁- and β₂-adrenoceptors in the melanophore of the goby Tridentiger obscurusKATAYAMA, H; MORISHITA, F; MATUSHIMA, O et al.Pigment cell research. 1990, Vol 3, Num 4, pp 192-199, issn 0893-5785, 8 p.Article

The biliary elimination of the selective beta-receptor blocking drug talinolol in manTERHAAG, B; GRAMATTE, T; RICHTER, K et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1989, Vol 27, Num 4, pp 170-172, issn 0174-4879Article

Evidence for two atypical conformations of beta-adrenoceptors and their interaction with Gi proteinsSANTOS, Iraides N; SUMITAME, Marie; CACERES, Viviane M et al.European journal of pharmacology. 2005, Vol 513, Num 1-2, pp 109-118, issn 0014-2999, 10 p.Article

A comparison of the β₁-selectivity of three β₁-selective β-blockersNUTTALL, S. L; ROUTLEDGE, H. C; KENDALL, M. J et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 3, pp 179-186, issn 0269-4727, 8 p.Article

Evaluation of cardiac β₁-adrenergic sensitivity with dobutamine in healthy volunteersPOUSSET, F; CHALON, S; THOMARE, P et al.British journal of clinical pharmacology. 1995, Vol 39, Num 6, pp 633-639, issn 0306-5251Article

Changes in myocardial and vascular receptors in heart failureBRISTOW, M. R.Journal of the American College of Cardiology. 1993, Vol 22, Num 4, pp 61A-71A, issn 0735-1097, SUPAConference Paper

New therapy update : metoprolol succinateSCARPA, W. J.Cardiovascular reviews & reports. 1992, Vol 13, Num 10, issn 0197-3118, p. 72Article

Spectrophotometric determination of atenolol via hydroxamic acid formationAGRAWAL, I. K; RAMAN, K. MISS; RAJPUT, S. MRS et al.Analytical letters. 1992, Vol 25, Num 8, pp 1503-1510, issn 0003-2719Article

Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivololDE CREE#, J; COBO, C; GEUKENS, H et al.Angiology. 1990, Vol 41, Num 2, pp 95-105, issn 0003-3197, 11 p.Article

Etude clinique du xamotérol, agoniste partiel, dans les valvulopathiesTOYOMASU, K.Yakuri to chiryo. 1988, Vol 16, Num 5, pp 279-287, issn 0386-3603Article

Effect of β₁-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal manTHAMSBORG, G; SYKULSKI, R; LARSEN, J et al.Clinical physiology (Oxford). 1987, Vol 7, Num 4, pp 313-318, issn 0144-5979Article

Metabolism of excercising skeletal muscle during beta₁-selective adrenoceptor blockadeHARTLING, O. J; SCHIBYE, B; KLAUSEN, K et al.Clinical physiology (Oxford). 1986, Vol 6, Num 5, pp 431-438, issn 0144-5979Article

Cloning and sequence analysis of the human β₁-adrenergic receptor 5'-flanking promoter regionCOLLINS, S; OSTROWSKI, J; LEFKOWITZ, R. J et al.Biochimica et biophysica acta, N. Gene structure and expression. 1993, Vol 1172, Num 1-2, pp 171-174, issn 0167-4781Article

Noradrenaline kinetics and coronary haemodynamics during acute β₁-adrenoceptor blockade in manMCCANCE, A. J; FORFAR, J. C.Clinical science (1979). 1993, Vol 84, Num 4, pp 413-417, issn 0143-5221Article

Use of electrofocusing for the analysis and purification of turkey erythrocytes β₁-adrenoceptorsMARBACH, I; LEVITZKI, A.FEBS letters. 1988, Vol 233, Num 1, pp 186-190, issn 0014-5793Article